The post MicroStrategy News: Michael Saylor Acknowledges Quantum Risks As A Real Threat To Bitcoin appeared on BitcoinEthereumNews.com. Key Insights: In the latestThe post MicroStrategy News: Michael Saylor Acknowledges Quantum Risks As A Real Threat To Bitcoin appeared on BitcoinEthereumNews.com. Key Insights: In the latest

MicroStrategy News: Michael Saylor Acknowledges Quantum Risks As A Real Threat To Bitcoin

Key Insights:

  • In the latest MicroStrategy news, the firm has revealed security risks that may impact Bitcoin.
  • Michael Saylor fuels concern over the long-term quantum risks in crypto.
  • MSTR stock struggles to regain the bullish support amid a broader crypto market selloff.

Quantum computing concerns just made MicroStrategy news after the company reportedly issued its stance on the matter. Rapid quantum advancements have some analysts on the edge given the technology’s potential for disruption in an industry heavily reliant on cryptography.

According to the latest MicroStrategy news, the company has officially acknowledged that quantum risks may plague Bitcoin in the long term.

Google AI lead Jeff Dean predicted that commercial and practical quantum applications could happen as soon as within 5 years. Notably, MicroStrategy sees this as a potential threat to Bitcoin within the next 10 years.

MicroStrategy News: Michael Saylor on Quantum Threats to Bitcoin | Source: Coin Bureau, X

MicroStrategy Launches Bitcoin Security Program for Quantum Risks

Michael Saylor, the chairman of MicroStrategy, recently revealed that the company is already making strides towards future-proofing against quantum risks.

He confirmed the creation of a Bitcoin security program that will “coordinate with the global cyber, crypto and BTC security community” to develop quantum-resistant cryptography.

As per the MicroStrategy news, Michael Saylor called this move a long-term play to secure the future of Bitcoin, given that the practicality of such sophisticated attacks is still at least 5 years away.

According to Deloitte research, it would take a quantum computer about 30 minutes to hack a Bitcoin signature.

However, with millions of transactions taking place on the network every minute, such a computer would need to work at currently-impossible seconds or microseconds to successfully “hack” the Bitcoin blockchain.

Saylor hopes that by the time this is possible, blockchain quantum resilience will have been developed and perfected.

Latest MicroStrategy news continues to drive MSTR stock performance as it jumped 26% to around $135 on Monday, kicking off the week on a bullish note.

This is after the stock dropped 17% last week, on Thursday, and closed at $106.99. According to an 8-K filing with the Securities and Exchange Commission on Monday, the company announced it has acquired another 1,142 BTC for approximately $90 million at an average price of $78,815.

MicroStrategy news showed that the firm now holds 714,644 BTC (~$49 billion), which it bought for ~$76,056 per BTC at a total cost of $54.4 billion, per The Block.

Meanwhile, players on the Polymarket prediction platform made a killing after the prediction of Strategy purchasing more than 1,000 BTC between February 3 and February 9 came to pass, following a 1,000+ BTC purchase by the company.

MicroStrategy News: Betting Market on Strategy’s BTC Buying | Source: Polymarket

At this price, MicroStrategy is approximately 9.2% in the red on all BTC it owns. Strategy CEO Phong Le said, “Bitcoin would need to drop to and remain at $8,000 for 5-6 years before any balance sheet issues emerge.”

What this Means for MicroStrategy and Bitcoin Investors?

MicroStrategy remains the ultimate Bitcoin proxy as they continue stacking and future-proofing. Even after last week’s 17% drop on the MSTR stock that wiped over $12 billion from the market cap, Strategy remains resilient, bagging even more BTC as Bitcoin strategy conviction remains high.

For MicroStrategy (MSTR) holders, the 26% gains on Monday have renewed hopes for their portfolio. Fresh BTC buys and talks of long-term security moves signal Strategy is here to stay.

Meanwhile, Bitcoin price is up 2.9% and trading at $69,397 as of 9:44 a.m. ET, moving in a tight range between $69,000 and $70,000 over the past 3 days.

Bitcoin Price | Source: TradingView

The price action is firmly below the 50-day and 200-day Simple Moving Averages (SMA), further cementing the bearish pressure on the asset.

The Relative Strength Index (RSI) is currently at 32.35 after whipsawing from the oversold region. In the past year, the RSI has dipped into the oversold region only once before, making market analysts suspect BTC may have bottomed.

Data from Coinglass Derivatives Visualizer shows both Bitcoin’s Open Interest and price are down, a combination that signals that futures traders are closing longs.

Bitcoin Price & OI | Source: Coinglass

BTC price might face a precarious position if longs exit in favor of short positions. This outcome may underscore more capitulation risk.

Source: https://www.thecoinrepublic.com/2026/02/10/microstrategy-news-michael-saylor-acknowledges-quantum-risks-as-a-real-threat-to-bitcoin/

Market Opportunity
QUANTUM Logo
QUANTUM Price(QUANTUM)
$0.003394
$0.003394$0.003394
-1.59%
USD
QUANTUM (QUANTUM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26